18 March 2026, Bhopal
The 10-day short course on “Next-Generation Diagnostics and Vaccines for Infectious Diseases: From Rational Design to Commercialization,” held from 9–18 March 2026 and organized by ICAR–National Institute of High Security Animal Diseases, Bhopal, concluded today.
Dr Aniket Sanyal, Director, ICAR-NIHSAD, emphasized the urgent need for innovative diagnostic platforms and advanced vaccine technologies that offer improved sensitivity, specificity, safety, and scalability. This is particularly important in light of the on-going emergence and re-emergence of transboundary and zoonotic pathogens.
The course covered advanced vaccine platforms and technologies, including DIVA-enabled live-attenuated vaccines, trans-amplifying mRNA vaccines, Virus-like particles strategies, VSV-based vaccine platforms, and reverse genetics systems for influenza vaccine development. It also featured cutting-edge diagnostics, such as synthetic biology-inspired diagnostic platforms, CRISPR-based detection, and microfluidics.
The participants received hands-on training in techniques like rescuing of influenza viruses, recombinant protein expression using baculovirus systems, lipid and gold nanoparticles synthesis and characterization, and high-throughput micro-neutralization assays for SARS-CoV-2.
In addition, the course introduced translational research concepts through lectures on technology transfer, patent strategies, start-up opportunities, and commercialization pathways. The course served as an outstanding platform for capacity building in the domains of next-generation diagnostics and vaccines development.
Fourteen participants from eight states across India, representing a vibrant blend of disciplines veterinary microbiology, biotechnology, physiology, biochemistry, veterinary medicine, epidemiology, and parasitology attended the program.
(Source: ICAR-National Institute of High Security Animal Diseases, Bhopal)
फेसबुक पर लाइक करें
यूट्यूब पर सदस्यता लें
X पर फॉलो करना X
इंस्टाग्राम पर लाइक करें